Patents by Inventor Pedro GOIS

Pedro GOIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Boronated Multifunctional Targeting Drug Conjugates, Their Uses and Methods for Their Preparation
    Publication number: 20240150379
    Abstract: Tri-component multi-functional boronated complexes (B-complexes), featuring reversible covalent bonds, are described, which incorporate a drug; a water-soluble moiety (e.g. polyethylene glycol (PEG) chains, cyclodextrins); and a targeting unit. A B-complex core was assembled in one step, and proved to be stable in different biocompatible conditions, such as human plasma, though reversible for example in the presence of glutathione (GSH). This platform enabled the modular construction of the multifunctional conjugates exhibiting high selectivity towards, for example, folate-receptor-positive MDA-MB-231 cancer cells, having an IC50 in the low nanomolar range.
    Type: Application
    Filed: December 13, 2023
    Publication date: May 9, 2024
    Inventors: Pedro GOIS, Fabio SANTOS
  • Boronated multifunctional targeting drug conjugates, their uses and methods for their preparation
    Patent number: 11884687
    Abstract: Tri-component multi-functional boronated complexes (B-complexes), featuring reversible covalent bonds, are described, which incorporate a drug; a water-soluble moiety (e.g. polyethylene glycol (PEG) chains, cyclodextrins); and a targeting unit. A B-complex core was assembled in one step, and proved to be stable in different biocompatible conditions, such as human plasma, though reversible for example in the presence of glutathione (GSH). This platform enabled the modular construction of the multifunctional conjugates exhibiting high selectivity towards, for example, folate-receptor-positive MDA-MB-231 cancer cells, having an IC50 in the low nanomolar range.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: January 30, 2024
    Assignee: Hovione Scientia Limited
    Inventors: Pedro Gois, Fabio Santos
  • Boronated Multifunctional Targeting Drug Conjugates, Their Uses and Methods for Their Preparation
    Publication number: 20200010484
    Abstract: Tri-component multi-functional boronated complexes (B-complexes), featuring reversible covalent bonds, are described, which incorporate a drug; a water-soluble moiety (e.g. polyethylene glycol (PEG) chains, cyclodextrins); and a targeting unit. A B-complex core was assembled in one step, and proved to be stable in different biocompatible conditions, such as human plasma, though reversible for example in the presence of glutathione (GSH). This platform enabled the modular construction of the multifunctional conjugates exhibiting high selectivity towards, for example, folate-receptor-positive MDA-MB-231 cancer cells, having an IC50 in the low nanomolar range.
    Type: Application
    Filed: March 1, 2018
    Publication date: January 9, 2020
    Inventors: Pedro GOIS, Fabio SANTOS